#17. Appen's acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more! episode artwork

EPISODE · Mar 13, 2019 · 42 MIN

#17. Appen's acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!

from Three Wise Monkeys Podcast · host Three Wise Monkeys

This week, we dissect Appen's latest acquisition and touch on the ethics of AI. We look to why shares in Envirosuite have surged higher, and ask whether the phenomenal gains from Clinuvel Pharmaceuticals and Advance NanoTek can continue. Plus Matt updates us on his recent meeting with the PushPay team. For more great content, please visit us at www.strawman.com, www.mattjoass.com & www.ethicalequities.com.au Email us at [email protected] And find us on Twitter @sage_simian @mattjoass @claudedwalker

Episode metadata supplied by the publisher feed · Published Mar 13, 2019

Embed this episode

Ready to play

#17. Appen's acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!

0:00 42:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Three Wise Monkeys Podcast?

This episode is 42 minutes long.

When was this Three Wise Monkeys Podcast episode published?

This episode was published on March 13, 2019.

Can I download this Three Wise Monkeys Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!